Merck & Co News

Merck & Co Analyst Ratings

BenzingaApr 18 09:57 ET

Merck & Co Analyst Ratings

BenzingaApr 8 08:09 ET

Merck & Company (MRK) Receives a Buy From Cantor Fitzgerald

TipRanksApr 6 00:15 ET

Merck & Co Analyst Ratings

BenzingaApr 5 09:27 ET

Merck & Co Analyst Ratings

BenzingaApr 1 08:37 ET

Buy Rating on Merck & Co. Affirmed by Daina Graybosch Amidst WINREVAIR's Market Potential and Efficacy

TipRanksMar 29 03:06 ET

Merck & Co Analyst Ratings

BenzingaMar 28 11:40 ET

Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating

MT NewswiresMar 27 11:15 ET

Merck & Co Analyst Ratings

BenzingaMar 27 08:36 ET

Maintaining Hold on Merck & Co. Amidst Sotatercept's Promising Developments and Revised Sales Projections

TipRanksMar 27 05:46 ET

Merck & Company (MRK) Gets a Buy From Cantor Fitzgerald

TipRanksMar 12 00:15 ET

Societe General Cuts Merck to Sell, Cites Keytruda Patent Expiry

Seeking AlphaMar 11 13:00 ET

Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target

BenzingaMar 11 09:20 ET

Merck & Co Analyst Ratings

BenzingaMar 11 09:17 ET

Critical Insights From Merck & Co Analyst Ratings: What You Need To Know

BenzingaFeb 29 14:01 ET

Merck & Co Analyst Ratings

BenzingaFeb 29 13:44 ET

Merck & Co Analyst Ratings

BenzingaFeb 14 11:31 ET

Merck & Co Analyst Ratings

BenzingaFeb 5 11:17 ET

Merck & Co: Strong Buy Rating on Robust Q4 Earnings and Promising Pipeline Outlook

TipRanksFeb 5 04:16 ET

Merck & Co Analyst Ratings

BenzingaFeb 2 14:55 ET